Pharmafile Logo

entecavir

Bristol-Myers Squibb (BMS) building

BMS halts hep C candidate development after patient death

Promises to share drug data to assist other pharma companies’ patient safety measures

Bristol-Myers Squibb (BMS) building

BMS halts trial of hepatitis C drug on safety issues

At least one person in study thought to have developed congestive heart failure

- PMLiVE

Interview: Greg Perry, European Generic medicines Association

The director general of the European Generic medicines Association talks to Liz Wells about the challenges facing generic drug manufacturers and discusses how his organisation is working to boost the...

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links